A citation-based method for searching scientific literature

Belén López-Muñiz Ballesteros, Marta López-Herranz, Ana Lopez-de-Andrés, Valentín Hernandez-Barrera, Rodrigo Jiménez-García, David Carabantes-Alarcon, Isabel Jiménez-Trujillo, Javier de Miguel-Diez. J Clin Med 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Natural history of idiopathic pulmonary fibrosis.
Hyun Joo Kim, David Perlman, Rade Tomic. Respir Med 2015
74
100

The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis.
Steven D Nathan, Taylor Reffett, A Whitney Brown, Chelsea P Fischer, Oksana A Shlobin, Shahzad Ahmad, Nargues Weir, Michael J Sheridan. Chest 2013
38
100

Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.
David Bennett, Martina Salvini, Annalisa Fui, Giuseppe Cillis, Paolo Cameli, Maria Antonietta Mazzei, Antonella Fossi, Rosa Metella Refini, Paola Rottoli. Inflammation 2019
16
100

Quality of life of idiopathic pulmonary fibrosis patients.
J De Vries, B L Kessels, M Drent. Eur Respir J 2001
129
100

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
100

Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.
Athol U Wells, Sujal R Desai, Michael B Rubens, Nicole S L Goh, Derek Cramer, Andrew G Nicholson, Thomas V Colby, Roland M du Bois, David M Hansell. Am J Respir Crit Care Med 2003
429
100

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
100

Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis.
Huifang Song, Dejun Sun, Chengjun Ban, Yan Liu, Min Zhu, Qiao Ye, Wei Yan, Yanhong Ren, Huaping Dai. Med Sci Monit 2019
8
100

The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.
Alessandro G Fois, Panagiotis Paliogiannis, Valentina Scano, Stefania Cau, Sergio Babudieri, Roberto Perra, Giulia Ruzzittu, Elisabetta Zinellu, Pietro Pirina, Ciriaco Carru,[...]. Molecules 2020
28
100

Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis.
Osamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, Takashi Iwanaga, Yuji Higashimoto, Hiroaki Kume, Yuji Tohda. Respirology 2017
21
100

Pathologic Regulation of Collagen I by an Aberrant Protein Phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 Signal Axis in Idiopathic Pulmonary Fibrosis Fibroblasts.
Wajahat Khalil, Hong Xia, Vidya Bodempudi, Judy Kahm, Polla Hergert, Karen Smith, Mark Peterson, Matthew Parker, Jeremy Herrera, Peter B Bitterman,[...]. Am J Respir Cell Mol Biol 2015
32
100

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Nicoline M Korthagen, Coline H M van Moorsel, Nicole P Barlo, Henk J T Ruven, Adrian Kruit, Michiel Heron, Jules M M van den Bosch, Jan C Grutters. Respir Med 2011
78
100

Mortality Associated with Idiopathic Pulmonary Fibrosis in Northeastern Italy, 2008-2020: A Multiple Cause of Death Analysis.
Alessandro Marcon, Elena Schievano, Ugo Fedeli. Int J Environ Res Public Health 2021
1
100

Body mass index and mortality in patients with idiopathic pulmonary fibrosis.
Mazen Alakhras, Paul A Decker, Hassan F Nadrous, Maria Collazo-Clavell, Jay H Ryu. Chest 2007
77
100

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab.
Carlo Putzu, Diego Luigi Cortinovis, Francesca Colonese, Stefania Canova, Ciriaco Carru, Angelo Zinellu, Panagiotis Paliogiannis. Cancer Immunol Immunother 2018
24
100

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
Martin Kolb, Ganesh Raghu, Athol U Wells, Jürgen Behr, Luca Richeldi, Birgit Schinzel, Manuel Quaresma, Susanne Stowasser, Fernando J Martinez. N Engl J Med 2018
104
100


Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis.
Pelagia G Tsoutsou, Konstantinos I Gourgoulianis, Efthymia Petinaki, Anastassios Germenis, Anthousa G Tsoutsou, Maria Mpaka, Smaragda Efremidou, Pashalis-Adam Molyvdas. Respir Med 2006
36
100

A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018.
Michael T Durheim, Jennifer Judy, Shaun Bender, Megan L Neely, Dorothy Baumer, Scott B Robinson, Craig S Conoscenti, Thomas B Leonard, Howard M Lazarus, Scott M Palmer. Medicine (Baltimore) 2020
3
100

The red blood cell distribution width.
T C Evans, D Jehle. J Emerg Med 1991
198
100

Idiopathic pulmonary fibrosis: outcome in relation to smoking status.
Katerina M Antoniou, David M Hansell, Michael B Rubens, Katharina Marten, Sujal R Desai, Nikolaos M Siafakas, Andrew G Nicholson, Roland M du Bois, Athol U Wells. Am J Respir Crit Care Med 2008
116
100

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Bartolome R Celli, Claudia G Cote, Jose M Marin, Ciro Casanova, Maria Montes de Oca, Reina A Mendez, Victor Pinto Plata, Howard J Cabral. N Engl J Med 2004
100

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
100

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.
Kevin R Flaherty, Jeanette A Mumford, Susan Murray, Ella A Kazerooni, Barry H Gross, Thomas V Colby, William D Travis, Andrew Flint, Galen B Toews, Joseph P Lynch,[...]. Am J Respir Crit Care Med 2003
359
100

Macrophages in Tissue Repair, Regeneration, and Fibrosis.
Thomas A Wynn, Kevin M Vannella. Immunity 2016
100

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.
T E King, M I Schwarz, K Brown, J A Tooze, T V Colby, J A Waldron, A Flint, W Thurlbeck, R M Cherniack. Am J Respir Crit Care Med 2001
447
100

Determinants of survival in idiopathic pulmonary fibrosis.
D A Schwartz, R A Helmers, J R Galvin, D S Van Fossen, K L Frees, C S Dayton, L F Burmeister, G W Hunninghake. Am J Respir Crit Care Med 1994
261
100

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.
Omkar Desai, Julia Winkler, Maksym Minasyan, Erica L Herzog. Front Med (Lausanne) 2018
88
100

Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis.
Angelo Zinellu, Panagiotis Paliogiannis, Elisabetta Sotgiu, Sabrina Mellino, Arduino A Mangoni, Elisabetta Zinellu, Silvia Negri, Claudia Collu, Gianfranco Pintus, Antonello Serra,[...]. Lung 2020
6
100

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
100

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
Harold R Collard, Talmadge E King, Becki Bucher Bartelson, Jason S Vourlekis, Marvin I Schwarz, Kevin K Brown. Am J Respir Crit Care Med 2003
485
100

Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.
Hassan F Nadrous, Jay H Ryu, William W Douglas, Paul A Decker, Eric J Olson. Chest 2004
66
100

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
T E King, J A Tooze, M I Schwarz, K R Brown, R M Cherniack. Am J Respir Crit Care Med 2001
596
100

Neutrophil-To-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease.
Victoria Maria Ruta, Adina Milena Man, Teodora Gabriela Alexescu, Nicoleta Stefania Motoc, Simina Tarmure, Rodica Ana Ungur, Doina Adina Todea, Sorina Cezara Coste, Dan Valean, Monica Carmen Pop. Medicina (Kaunas) 2020
3
100

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
K B Baumgartner, J M Samet, C A Stidley, T V Colby, J A Waldron. Am J Respir Crit Care Med 1997
438
100

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.
Jürgen Behr, Michael Kreuter, Marius M Hoeper, Hubert Wirtz, Jens Klotsche, Dirk Koschel, Stefan Andreas, Martin Claussen, Christian Grohé, Henrike Wilkens,[...]. Eur Respir J 2015
130
100

Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity.
M W Ziegenhagen, P Zabel, G Zissel, M Schlaak, J Müller-Quernheim. Am J Respir Crit Care Med 1998
92
100



Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study.
E Prescott, T Almdal, K L Mikkelsen, C L Tofteng, J Vestbo, P Lange. Eur Respir J 2002
153
100

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
Ai-Ping Yang, Jian-Ping Liu, Wen-Qiang Tao, Hui-Ming Li. Int Immunopharmacol 2020
289
100

Complete Blood Cell Count-Derived Inflammation Biomarkers in Men with Age-Related Macular Degeneration.
Antonio Pinna, Tiziana Porcu, Giuseppe D'Amico-Ricci, Stefano Dore, Francesco Boscia, Panagiotis Paliogiannis, Ciriaco Carru, Angelo Zinellu. Ocul Immunol Inflamm 2019
11
100

Predictive values of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and other prognostic factors in pediatric idiopathic sudden sensorineural hearing loss.
Ryun Ha, Byeoung Woo Lim, Dong Hyun Kim, Jung Woo Park, Chang Hyun Cho, Ju Hyoung Lee. Int J Pediatr Otorhinolaryngol 2019
8
100

Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis.
Gian Luca Erre, Panagiotis Paliogiannis, Floriana Castagna, Arduino Aleksander Mangoni, Ciriaco Carru, Giuseppe Passiu, Angelo Zinellu. Eur J Clin Invest 2019
43
100

Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status.
Tomoo Kishaba, Hiroaki Nagano, Yuichiro Nei, Shin Yamashiro. J Thorac Dis 2016
19
100

Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis.
Panagiotis Paliogiannis, Rosanna Satta, Giovanni Deligia, Giuseppina Farina, Stefania Bassu, Arduino A Mangoni, Ciriaco Carru, Angelo Zinellu. Clin Exp Med 2019
24
100

Neutrophil-to-lymphocyte ratio as an independent inflammatory indicator of poor prognosis in IgA nephropathy.
Qianqian Li, Ping Chen, Sufang Shi, Lijun Liu, Jicheng Lv, Li Zhu, Hong Zhang. Int Immunopharmacol 2020
5
100


Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
Lucile Sesé, Hilario Nunes, Vincent Cottin, Dominique Israel-Biet, Bruno Crestani, Stephanie Guillot-Dudoret, Jacques Cadranel, Benoit Wallaert, Abdellatif Tazi, Bernard Maître,[...]. Front Med (Lausanne) 2021
2
100

IC4: a new combined predictive index of mortality in idiopathic pulmonary fibrosis.
Angelo Zinellu, Claudia Collu, Elisabetta Zinellu, Kaïs Ahmad, Mouhamad Nasser, Julie Traclet, Elisabetta Sotgiu, Sabrina Mellino, Arduino A Mangoni, Ciriaco Carru,[...]. Panminerva Med 2021
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.